In vivo evaluation of pharmacologically active microcarriers releasing nerve growth factor and conveying PC12 cells

Cell Transplantation

Volumn 13, Issue 5, 2004, Pages 573-583

  Tatard, V M ^a   Venier Julienne, M C ^a   Benoit, J P ^a   Menei, P ^a,b   Montero Menei, C N ^a  

^a INSERM   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cell adhesion; Cell therapy; Microcarriers; Nerve growth factor; Parkinson's disease; PC12 cells

Indexed keywords

AMPHETAMINE; CELL ADHESION MOLECULE; FIBRONECTIN; NERVE GROWTH FACTOR; POLY DEXTRO LYSINE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL SURVIVAL; CELL TRANSPLANTATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; EVALUATION; FEMALE; IN VIVO STUDY; MICROCARRIER CULTURE; MICROENVIRONMENT; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; SURFACE PROPERTY;

ANIMALIA;

EID: 9344232785     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783983675     Document Type: Article

References (50)

1. Aebischer, P.; Winn, S. R.; Tresco, P. A.; Jaeger, C. B.; Greene, L. A. Transplantation of polymer encapsulated neurotransmitter secreting cells: Effect of the encapsulation technique. J. Biomech. Eng. 113:178-183; 1991.
2. 2+-responsible secretory vesicles through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J. Biochem. (Tokyo) 131:887-894; 2002.
3. Amoureux, M. C.; Cunningham, B. A.; Edelman, G. M.; Crossin, K. L. N-CAM binding inhibits the proliferation of hippocampal progenitor cells and promotes their differentiation to a neuronal phenotype. J. Neurosci. 20:3631-3640; 2000.
4. Baldwin, S. P.; Krewson, C. E.; Saltzman, W. M. PC12 cell aggregation and neurite growth in gels of collagen, laminin and fibronectin. Int. J. Dev. Neurosci. 14:351-364; 1996.
5. Bing, G. Y.; Notter, M. F.; Hansen, J. T.; Gash, D. M. Comparison of adrenal medullary, carotid body and PC 12 cell grafts in 6-OHDA lesioned rats. Brain Res. Bull. 20: 399-406; 1988.
6. Bjorklund, L. M.; Sanchez-Pernaute, R.; Chung, S.; Andersson, T.; Chen, I. Y.; McNaught, K. S.; Brownell, A. L.; Jenkins, B. G.; Wahlestedt, C.; Kim, K. S.; Isacson, O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 99:2344-2349; 2002.
7. Borlongan, C. V.; Saporta, S.; Sanberg, P. R. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats. Exp. Neural. 151:203-214; 1998.
8. Brundin, P.; Karlsson, J.; Emgard, M.; Schierle, G. S.; Hansson, E.; Petersen, A.; Castilho, R. F. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant. 9:179-195; 2000.
9. Burstein, D. E.; Blumberg, P. M.; Greene, L. A. Nerve growth factor-induced neuronal differentiation of PC 12 pheochromocytoma cells: Lack of inhibition by a tumor promoter. Brain Res. 247:115-119; 1982.
10. Cao, X.; Shoichet, M. S. Defining the concentration gradient of nerve growth factor for guided neurite outgrowth. Neuroscience 103:831-840; 2001.
11. Cherksey, B. D.; Sapirstein, V. S.; Geraci, A. L. Adrenal chromaffin cells on microcarriers exhibit enhanced long-term functional effects when implanted into the mammalian brain. Neuroscience 75:657-664; 1996.
12. Dehaut, F.; Montero-Menei, C.; Alhayek, G.; Pouplard-Barthelaix, A. Differential behaviour of PC12 cells grafted into rat hippocampus and striatum. Neurosci. Lett. 153: 41-44; 1993.
13. Desmarais, D.; Royal, A. The TATA motif is a target for efficient transcriptional activation and nerve growth factor induction of the peripherin gene. J. Biol. Chem. 271: 24976-24981; 1996.
14. Dichter, M. A.; Tischler, A. S.; Greene, L. A. Nerve growth factor-induced increase in electrical excitability and acetylcholine sensitivity of a rat pheochromocytoma cell line. Nature 268:501-504; 1977.
15. Escurat, M.; Djabali, K.; Gumpel, M.; Gros, F.; Portier, M. M. Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecularmass neurofilament protein (NF-L), during the development of the rat. J. Neurosci. 10:764-784; 1990.
16. Frazza, E. J.; Schmitt, E. E. A new absorbable suture. J. Biomed. Mater. Res. 5:43-58; 1971.
17. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:710-719; 2001.
18. Greene, L. A. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78:747-755; 1978.
19. Greene, L. A.; Tischler, A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428; 1976.
20. Hagell, P.; Brundin, P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J. Neuropathol. Exp. Neural. 60:741-752; 2001.
21. Hauser, R. A.; Furtado, S.; Cimino, C. R.; Delgado, H.; Eichler, S.; Schwartz, S.; Scott, D.; Nauert, G. M.; Soety, E.; Sossi, V.; Holt, D. A.; Sanberg, P. R.; Stoessl, A. J.; Freeman, T. B. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58:687-695; 2002.
22. Hefti, F.; Hartikka, J.; Schlumpf, M. Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res. 348:283-288; 1985.
23. Jaeger, C. B.; Greene, L. A.; Tresco, P. A.; Winn, S. R.; Aebischer, P. Polymer encapsulated dopaminergic cell lines as "alternative neural grafts." Prog. Brain Res. 82: 41-46; 1990.
24. Jollivet, C.; Aubert-Pouessel, A.; Clavreul, A.; Venier-Julienne, M. C.; Montero-Menei, C. N.; Benoit, J. P.; Menei, P. Reconstruction of nigro-striatal dopaminergic innervation by implantation of GDNF-releasing biodegradable microspheres. Biomaterials; 2003.
25. Korbling, M.; Fliedner, T. M. The evolution of clinical peripheral blood stem cell transplantation. Bone Marrow Transplant. 17:675-678; 1996.
26. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P.; Olanow, C. W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
27. Levi, A.; Biocca, S.; Cattaneo, A.; Calissano, P. The mode of action of nerve growth factor in PC12 cells. Mol. Neurobiol. 2:201-226; 1988.
28. Lindner, M. D.; Emerich, D. F. Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine-producing cell line in rodent and primate models of Parkinson's disease. Cell Transplant. 7:165-174; 1998.
29. Lindvall, O. Neural transplantation: A hope for patients with Parkinson's disease. Neuroreport 8:iii-x; 1997.
30. Mahoney, M. J.; Saltzman, W. M. Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nat. Biotechnol. 19:934-939; 2001.
31. Margis, R.; Borojevic, R. Quantification of attached cells in tissue culture plates and on microcarriers. Anal. Biochem. 181:209-211; 1989.
32. Menei, P.; Benoit, J. P.; Boisdron-Celle, M.; Fournier, D.; Mercier, P.; Guy, G. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery 34:1058-1064; 1994.
33. Menei, P.; Daniel, V.; Montero-Menei, C.; Brouillard, M.; Pouplard-Barthelaix, A.; Benoit, J. P. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 14:470-478; 1993.
34. Menei, P.; Nerriere-Daguin, V.; Jollivet, C.; Brachet, P.; Benoit, J. P. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp. Neurol. 161:259-272; 2000.
35. Menei, P.; Pouplard-Barthelaix, A.; Brachet, P.; Fournier, D.; Alhayek, G.; Mercier, P.; Guy, G. Intracerebral graft of a line of chromaffin cells. Immunologic aspects and role of nerve growth factor in survival and differentiation of the graft. Neurochirurgie 35:158-163; 1989.
36. Nagatoshi, Y.; Kawano, Y.; Watanabe, T.; Abe, T.; Okamoto, Y.; Kuroda, Y.; Takaue, Y.; Okamura, J. Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population. Pediatr. Transplant. 6: 319-326; 2002.
37. Park, K. I.; Teng, Y. D.; Snyder, E. Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 20: 1111-1117; 2002.
38. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates (4th ed.). New York: Academic Press; 1998.
39. Pean, J. M.; Menei, P.; Morel, O.; Montero-Menei, C. N.; Benoit, J. P. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. Biomaterials 21:2097-2101; 2000.
40. Pean, J. M.; Venier-Julienne, M. C.; Boury, F.; Menei, P.; Denizot, B.; Benoit, J. P. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J. Control Release 56:175-187; 1998.
41. Saporta, S.; Borlongan, C.; Moore, J.; Mejia-Millan, E.; Jones, S. L.; Bonness, P.; Randall, T. S.; Allen, R. C.; Freeman, T. B.; Sanberg, P. R. Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum. Cell Transplant. 6:579-584; 1997.
42. Sautter, J.; Tseng, J. L.; Braguglia, D.; Aebischer, P.; Spenger, C.; Seiler, R. W.; Widmer, H. R.; Zurn, A. D. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol. 149:230-236; 1998.
43. Subramanian, T.; Marchionini, D.; Potter, E. M.; Cornfeldt, M. L. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant. 11: 207-214; 2002.
44. Takano, N.; Kawakami, T.; Kawa, Y.; Asano, M.; Watabe, H.; Ito, M.; Soma, Y.; Kubota, Y.; Mizoguchi, M. Fibronectin combined with stem cell factor plays an important role in melanocyte proliferation, differentiation and migration in cultured mouse neural crest cells. Pigment Cell Res. 15:192-200; 2002.
45. Tate, M. C.; Shear, D. A.; Huffman, S. W.; Stein, D. G.; Archer, D. R.; LaPlaca, M. C. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant. 11:283-295; 2002.
46. Tornqvist, N.; Bjorklund, L.; Almqvist, P.; Wahlberg, L.; Stromberg, I. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Exp. Neurol. 164:130-138; 2000.
47. Ungerstedt, U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5: 107-110; 1968.
48. Veziers, J.; Lesourd, M.; Jollivet, C.; Montero-Menei, C.; Benoit, J. P.; Menei, P. Analysis of brain biocompatibility of drug-releasing biodegradable microspheres by scanning and transmission electron microscopy. J. Neurosurg. 95: 489-494; 2001.
49. Watts, R. L.; Stover, N. P.; Cornfeldt, M. L.; Schweikert, A. W.; Allen, R. C.; Subramanian, T.; Doudet, D.; Honey, C. R.; Bakay, R. A. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: A potential new cell therapy for Parkinson's disease. J. Neural Transm. Suppl. 65:215-227; 2003.
50. Zawada, W. M.; Zastrow, D. J.; Clarkson, E. D.; Adams, F. S.; Bell, K. P.; Freed, C. R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:96-103; 1998.